ENDOLOGIX INC's ticker is ELGX and the CUSIP is 29266S106. A total of 130 filers reported holding ENDOLOGIX INC in Q4 2015. The put-call ratio across all filers is 1.31 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $1,748,000 | -64.0% | 305,519 | -19.5% | 0.00% | -66.7% |
Q3 2016 | $4,861,000 | +3.8% | 379,750 | +1.0% | 0.01% | 0.0% |
Q2 2016 | $4,684,000 | +70.5% | 375,948 | +14.4% | 0.01% | +50.0% |
Q1 2016 | $2,748,000 | -13.0% | 328,656 | +3.0% | 0.00% | 0.0% |
Q4 2015 | $3,160,000 | -10.0% | 319,203 | +11.4% | 0.00% | -20.0% |
Q3 2015 | $3,513,000 | -12.3% | 286,528 | +9.7% | 0.01% | 0.0% |
Q2 2015 | $4,006,000 | +17.7% | 261,174 | +31.0% | 0.01% | +25.0% |
Q1 2015 | $3,403,000 | +27.6% | 199,336 | +14.3% | 0.00% | 0.0% |
Q4 2014 | $2,666,000 | +42.5% | 174,362 | -1.2% | 0.00% | +33.3% |
Q3 2014 | $1,871,000 | -29.9% | 176,510 | +0.5% | 0.00% | -25.0% |
Q2 2014 | $2,670,000 | +19.1% | 175,573 | +0.8% | 0.00% | +33.3% |
Q1 2014 | $2,242,000 | -25.5% | 174,214 | +0.9% | 0.00% | -25.0% |
Q4 2013 | $3,011,000 | +5.5% | 172,627 | -2.3% | 0.00% | -20.0% |
Q3 2013 | $2,853,000 | +29.7% | 176,780 | +6.7% | 0.01% | +25.0% |
Q2 2013 | $2,199,000 | – | 165,605 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tamarack Capital Management, LLC | 4,050,000 | $49,653,000 | 5.91% |
Essex Woodlands Management, Inc. | 1,257,468 | $21,220,000 | 3.88% |
PURA VIDA INVESTMENTS, LLC | 205,100 | $2,515,000 | 1.44% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,347,113 | $28,776,000 | 1.11% |
First Light Asset Management, LLC | 180,963 | $2,219,000 | 1.10% |
ArrowMark Colorado Holdings LLC | 2,889,546 | $35,426,000 | 0.97% |
PALISADE CAPITAL MANAGEMENT, LP | 2,149,949 | $26,358,000 | 0.78% |
Iguana Healthcare Management, LLC | 150,000 | $1,839,000 | 0.72% |
CADIAN CAPITAL MANAGEMENT, LP | 1,492,443 | $18,297,000 | 0.66% |
WASHINGTON CAPITAL MANAGEMENT, INC | 85,882 | $1,053,000 | 0.66% |